Not so far in the future,
doctors might prescribe a virtual beach vacation to calm aches and pains, in lieu of taking a pill. Insurance companies might offer scenic tours of Icelandic fjords to lower blood pressure, instead of doubling up on drugs. Psychiatrists might treat social phobia by immersing patients in a virtual dinner party.
It’s starting to happen right now because of virtual reality (VR) – the mind-bending technology that offers immersive, multisensory environments that nudge our brains into thinking we are somewhere else.
For decades, scientists have been discovering the surprising health benefits of VR for ailments ranging from burn injuries, to stroke, to posttraumatic stress. Thousands of studies reveal that VR has an uncanny ability to block pain, calm nerves and boost mental health – all without drugs and their unwanted side effects. But the technology has been too expensive, unreliable and unwieldy for the research to translate beyond the pages of academic journals and doctoral dissertations.
Anxiety RelieVR / appliedVR
Explosive advances in delivering low-cost, portable, and high-quality VR to the masses has spawned a new multibillion dollar field called Medical VR.
The next challenge is to scale and implement VR into everyday clinical practice. Clinicians and investigators are learning what works – and doesn’t work – in creating “Virtualist” consult services and VR programs for patient care.
Developed by the VR clinical research team at Cedars-Sinai Medical Center, with generous support from the Marc and Sheri Rapaport Fund for Digital Health Sciences and Precision Health, Virtual Medicine is a two-day symposium that convenes the brightest minds in immersive therapeutics. Attendees learn from case studies, didactic lectures, patient vignettes, and simulation workshops, to achieve the following educational objectives:
review evidence supporting the efficacy of medical VR.
study use cases where VR worked – and didn't work – to improve outcomes.
learn best practices and pragmatic tips for implementing VR into
discuss the cost-effectiveness and payer perspectives of therapeutic VR programs.
hear directly from patients who have received VR therapeutics.
VIRtual medicine is
who should attend
intended for a wide range of stakeholders seeking to learn about the implementation, outcomes, and cost-effectiveness of immersive virtual therapeutics in clinical practice and the role of VR and AR in medical education and simulation. Participants include clinicians using VR for patient care, patients exploring the benefits of VR as a complementary therapy, hospitals and clinics evaluating the health economics of starting a medical VR program, industry partners developing VR hardware and software solutions, journalists investigating the latest advances in medical VR, and investors seeking to learn the evidence and ROI for healthcare VR solutions.
In 2019 the 430 registrants came from 12 countries and 5 continents.
Please note that CME credits are not awarded for this conference.